These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12401276)

  • 21. Terlipressin in chronic hyperdynamic endotoxic shock: is it safe?
    Asfar P
    Intensive Care Med; 2003 Feb; 29(2):154-5. PubMed ID: 12674117
    [No Abstract]   [Full Text] [Related]  

  • 22. Terlipressin as rescue treatment of refractory shock in a neonate.
    Filippi L; Poggi C; Serafini L; Fiorini P
    Acta Paediatr; 2008 Apr; 97(4):500-2. PubMed ID: 18307552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pressure or flow?
    Westphal M; Ertmer C; Van Aken H; Bone HG
    Anaesth Intensive Care; 2004 Jun; 32(3):437-8; author reply 438-9. PubMed ID: 15264750
    [No Abstract]   [Full Text] [Related]  

  • 24. A case of ischemic skin necrosis after glypressin therapy in liver cirrhosis.
    Oh JE; Ha JS; Cho DH; Yu GJ; Shim SG
    Korean J Gastroenterol; 2008 Jun; 51(6):381-4. PubMed ID: 18604141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Terlipressin and reversible intestinal ischaemia].
    Hansen M; Bjerg J; Gilsaa T
    Ugeskr Laeger; 2007 May; 169(19):1802-3. PubMed ID: 17537358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Terlipressin for hepatorenal syndrome: continuous infusion as an alternative to i.v. bolus administration.
    Gerbes AL; Huber E; Gülberg V
    Gastroenterology; 2009 Sep; 137(3):1179; author reply 1179-81. PubMed ID: 19631603
    [No Abstract]   [Full Text] [Related]  

  • 27. Terlipressin infusion induces ischemia of breast skin in a cirrothic patient with hepatorenal syndrome.
    Di Micoli A; Bracci E; Cappa FM; Casadio R; Zambruni A; Fontana K; Bernardi M; Trevisani F
    Dig Liver Dis; 2008 Apr; 40(4):304-5. PubMed ID: 18160353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Terlipressin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transport.
    Westphal M; Stubbe H; Sielenkämper AW; Borgulya R; Van Aken H; Ball C; Bone HG
    Intensive Care Med; 2003 Feb; 29(2):301-8. PubMed ID: 12594590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock.
    Morelli A; Rocco M; Conti G; Orecchioni A; De Gaetano A; Cortese G; Coluzzi F; Vernaglione E; Pelaia P; Pietropaoli P
    Intensive Care Med; 2004 Apr; 30(4):597-604. PubMed ID: 14673520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is spontaneous bacterial peritonitis an inducer of vasopressin analogue side-effects? A case report.
    Vaccaro F; Giorgi A; Riggio O; De Santis A; Laviano A; Rossi-Fanelli F
    Dig Liver Dis; 2003 Jul; 35(7):503-6. PubMed ID: 12870738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Terlipressin as rescue therapy for intractable hypotension during neonatal septic shock.
    Matok I; Leibovitch L; Vardi A; Adam M; Rubinshtein M; Barzilay Z; Paret G
    Pediatr Crit Care Med; 2004 Mar; 5(2):116-8. PubMed ID: 14987339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
    Narahara Y; Kanazawa H; Taki Y; Kimura Y; Atsukawa M; Katakura T; Kidokoro H; Harimoto H; Fukuda T; Matsushita Y; Nakatsuka K; Sakamoto C
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose terlipressin for hemodynamic support in sepsis and systemic inflammatory response syndrome: art for (he)art's sake or state of the art?
    Westphal M; Traber DL
    Crit Care Med; 2005 Feb; 33(2):455-7. PubMed ID: 15699859
    [No Abstract]   [Full Text] [Related]  

  • 34. Extensive epidermal necrosis due to terlipressin.
    Yefet E; Gershovich M; Farber E; Soboh S
    Isr Med Assoc J; 2011 Mar; 13(3):180-1. PubMed ID: 21608341
    [No Abstract]   [Full Text] [Related]  

  • 35. [A case of peripheral ischemic complication after terlipressin therapy].
    Lee JS; Lee HS; Jung SW; Han WS; Kim MJ; Lee SW; Choi JH; Kim CD; Ryu HS; Hyun JH
    Korean J Gastroenterol; 2006 Jun; 47(6):454-7. PubMed ID: 16809953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical review: Vasopressin and terlipressin in septic shock patients.
    Delmas A; Leone M; Rousseau S; Albanèse J; Martin C
    Crit Care; 2005 Apr; 9(2):212-22. PubMed ID: 15774080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Terlipressin causing a hyponatraemic seizure.
    Dunwoodie E; Jowett S
    Scand J Gastroenterol; 2007 May; 42(5):665. PubMed ID: 17454890
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of terlipressin in pediatric septic shock: a review of the literature and personal experience.
    Papoff P; Mancuso M; Barbara CS; Moretti C
    Int J Immunopathol Pharmacol; 2007; 20(2):213-21. PubMed ID: 17624234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of terlipressin in the treatment of infants and neonates with catecholamine-resistant septic shock.
    Leone M; Martin C
    Best Pract Res Clin Anaesthesiol; 2008 Jun; 22(2):323-33. PubMed ID: 18683478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasopressin in sepsis and septic shock.
    Kampmeier TG; Rehberg S; Westphal M; Lange M
    Minerva Anestesiol; 2010 Oct; 76(10):844-50. PubMed ID: 20935620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.